David Mott

David Mott

Ordförande på ARDELYX, INC.

Förmögenhet: 21 M $ per 2026-05-31

60 år
Health Technology
Finance
Consumer Services

Profil

Mr. David M.
Mott
is an Independent Director at Novavax, Inc., a Chairman at Ardelyx, Inc. and a Chairman at Cydan LLC.
He is on the Board of Directors at Novavax, Inc., Biotechnology Innovation Organization, NEA 14 GP Ltd. and XTuit Pharmaceuticals, Inc. Mr. Mott was previously employed as a Chairman by Imara, Inc., an Independent Director by Clementia Pharmaceuticals, Inc., an Independent Non-Executive Director by Nightstar Therapeutics Plc, a Chairman by Adaptimmune Ltd., a Chairman by Adaptimmune Therapeutics Plc, a Chairman by Mersana Therapeutics, Inc., a Chairman-Supervisory Board by Prosensa Holding NV, a Chairman by Epizyme, Inc., a General Partner by NEA Management Co. LLC, a General Partner by New Enterprise Associates LLC, a Non-Executive Director by Shire Plc, an Executive Vice President by AstraZeneca PLC, a President by MedImmune Ventures, Inc., a Vice Chairman, President & Chief Executive Officer by MedImmune LLC, a President & Chief Executive Officer by MedImmune Ltd., a Vice President-Health Care Investment Banking by Smith Barney Harris Upham & Co., Inc., a Chairman by Complexa, Inc., a Chairman by Conceptis Technologies, Inc., a Chairman by Cydan II, Inc., a VP-Health Care Investment Banking Group by Harris Upham & Co, Inc., a Chairman by Sagimet Biosciences, Inc., a Member-Governing Board by St. Albans School, a Trustee by St. James' School, a Chairman by Vtesse, Inc., and a Chairman by Zyngenia, Inc. He also served on the board at Polyneuron Pharmaceuticals AG, Tiburio Therapeutics, Inc., Omthera Pharmaceuticals, Inc., Tesaro, Inc., Ambit Biosciences Corp., Biohealth Innovation, Inc., Edimer Pharmaceuticals, Inc., Melinta Subsidiary Corp., NightstaRx Ltd., Shire Pharmaceuticals, Inc., Shire Plc /Old/, Zosano Pharma Corp.
and ZP Opco, Inc. He received his undergraduate degree from Dartmouth College.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-03-31 3 302 918 ( 1,34 % ) 20 M $ 2026-05-31
2026-04-23 79 770 ( 0,05 % ) 875 077 $ 2026-05-31
2025-04-11 0 ( -.--% ) - $ 2026-05-31
2026-01-06 0 ( -.--% ) - $ 2025-12-31

Aktiva positioner av David Mott

FöretagPositionStart
ARDELYX, INC. Ordförande 2014-03-01
NOVAVAX, INC. Direktör/Styrelseledamot 2020-06-16
Ordförande -
NEA 14 GP Ltd.
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -

Tidigare kända positioner av David Mott

FöretagPositionSlut
MERSANA THERAPEUTICS Verkställande Direktör 2015-03-02
ADAPTIMMUNE THERAPEUTICS PLC Ordförande 2025-11-14
IMARA Ordförande 2023-02-01
░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░░ ░░░ ░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Se detaljerna i David Motts erfarenhet

David Motts utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

56

Första gradens relationer

45

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag45

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Technology Services

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Retail Trade

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

NEA 14 GP Ltd.

Health Technology

Health Technology

Distribution Services

Finance

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

  1. Börsen
  2. Insiders
  3. David Mott
- 40% : De bästa verktygen för abonnenter som vill hitta morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU